Arca Biopharma | ABIO - Ordinary Share Capital


Arca Biopharma reported $50.17M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Amgen USD 541M 1000K Jun/2026
Arca Biopharma USD 50.17M 1.45M Mar/2026
Biogen USD 146.7M 200K Sep/2025
Brainstorm Cell Therapeutics USD 11.04M 0 Mar/2026
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Capricor Therapeutics USD 57.37M 11.65M Dec/2025
Cipla INR 807.78M 17K Mar/2026
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 94.55M 1000 Mar/2026
CSL USD 482.13M 93.87M Dec/2025
Cytokinetics USD 124.43M 2.17M Mar/2026
Daiichi Sankyo JPY 1.82B 30.68M Jun/2026
Gilead Sciences USD 1.24B 1000K Jun/2026
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
Grifols EUR 680.58M 846.11K Dec/2025
Laboratory Of America USD 80.9M 1.4M Jun/2026
Myriad Genetics USD 93.5M 400K Dec/2025
Otsuka Holdings JPY 525.39M 1.91M Jun/2026
Pfizer USD 5.7B 0 Jun/2026
United Therapeutics USD 42.68M 521K Jun/2026